SELLAS Life Sciences Group, Inc. — Operating Income by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9765afb8-7d03-4788-ae6b-234d302406fb/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-28.3M | 2025-01-01 – 2025-12-31 | evidence 0001390478-26-000003 |
| FY 2024 | $-31.5M | 2024-01-01 – 2024-12-31 | evidence 0001390478-25-000003 |
| FY 2023 | $-37.9M | 2023-01-01 – 2023-12-31 | evidence 0001390478-24-000004 |
| FY 2022 | $-42.0M | 2022-01-01 – 2022-12-31 | evidence 0001390478-23-000005 |
| FY 2021 | $-25.3M | 2021-01-01 – 2021-12-31 | evidence 0001390478-22-000006 |
| FY 2020 | $-17.0M | 2020-01-01 – 2020-12-31 | evidence 0001390478-21-000007 |
| FY 2019 | $-20.0M | 2019-01-01 – 2019-12-31 | evidence 0001390478-21-000007 |
| FY 2017 | $-23.0M | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-117053 |
| FY 2016 | $-16.0M | 2016-01-01 – 2016-12-31 | evidence 0001193125-18-117053 |
| FY 2015 | $-34.2M | 2015-01-01 – 2015-12-31 | evidence 0001390478-16-000088 |
| FY 2014 | $-43.9M | 2014-01-01 – 2014-12-31 | evidence 0001390478-15-000057 |
| FY 2013 | $-28.5M | 2013-01-01 – 2013-12-31 | evidence 0001390478-15-000057 |
| FY 2012 | $-21.2M | 2012-01-01 – 2012-12-31 | evidence 0001390478-14-000016 |
| FY 2011 | $-12.5M | 2011-01-01 – 2011-12-31 | evidence 0001390478-14-000016 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SELLAS Life Sciences Group, Inc. — all facts · Revenue · Net Income